$23.7M Secured to Scale FDA-Cleared Digital Sleep, Anxiety Treatments
Following the establishment of new CMS reimbursement codes for digital mental health treatments, the funding will support the commercial expansion of two prescription products.
Following the establishment of new CMS reimbursement codes for digital mental health treatments, the funding will support the commercial expansion of two prescription products.
The two new reimbursement codes for the FDA-cleared wearable system go into effect on Oct 1.
With the integration of HSAT into clinical practice, applying the precise billing and coding is a critical—but often bewildering—task. This article outlines an easy process to facilitate reimbursement.
The American Academy of Sleep Medicine asks CMS and private payors to suspend the 90-day adherence rule for PAP therapy in the wake of the Philips recall.
Read MoreApproved as a Qualified Clinical Data Registry by CMS, Sleep CDR will support quality improvement efforts, collection of patient-reported outcomes data, and benchmarking.
Read MoreDuring the coronavirus pandemic, sleep professionals decide what procedures occur now and which are postponed, using general guidance from government agencies and professional associations.
Read MoreAfter requests from dental sleep medicine practitioners, the Centers for Medicare and Medicaid...
Read More